Department of Otolaryngology - Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Clin Otolaryngol. 2020 May;45(3):350-356. doi: 10.1111/coa.13505. Epub 2020 Feb 6.
Chronic rhinosinusitis (CRS) is a relatively common disease, which significantly affects the patient's quality of life (QoL). Sino-Nasal Outcome Test-22 (SNOT-22) is a QoL questionnaire, which allows quantifying patients' complaints. Our aim was to translate and validated the SNOT-22 into the Russian language.
Translation and validation of SNOT-22 questionnaire was performed through forward-backward translation technique. After proper translation, the translated questionnaire was completed by CRS patients before and after endoscopic sinus surgery (ESS) and by healthy individuals as controls.
Thirty-four native Russian-speaking CRS patients completed the Russian version of the SNOT-22 questionnaire before and after ESS. The internal consistency for reliability assessment was very good (mean Cronbach's alpha = 0.816 for CRS patients). Mean scores for the preoperative, postoperative and control groups were 67.6, 18.1 and 9.2, respectively (P < .001), showing validity and responsiveness of the questionnaire.
The Russian version of the SNOT-22 questionnaire is a valid outcome measure for patients with CRS.
慢性鼻-鼻窦炎（CRS）是一种较为常见的疾病，它会显著影响患者的生活质量（QoL）。鼻-鼻窦结局测试 22 项（SNOT-22）是一种 QoL 问卷，可以对患者的症状进行量化。我们的目的是将 SNOT-22 翻译成俄语并对其进行验证。
通过正向-反向翻译技术对 SNOT-22 问卷进行翻译和验证。经过适当的翻译，接受过内镜鼻窦手术（ESS）的 CRS 患者和健康对照组分别完成了翻译后的问卷。
34 名母语为俄语的 CRS 患者在接受 ESS 前后完成了 SNOT-22 问卷的俄语版。可靠性评估的内部一致性非常好（CRS 患者的平均 Cronbach's alpha 为 0.816）。术前、术后和对照组的平均得分分别为 67.6、18.1 和 9.2（P <.001），表明了问卷的有效性和反应性。
SNOT-22 问卷的俄语版是评估 CRS 患者的有效结果测量工具。
